<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02490384</url>
  </required_header>
  <id_info>
    <org_study_id>ThomasJeffersonU</org_study_id>
    <nct_id>NCT02490384</nct_id>
  </id_info>
  <brief_title>Physical Exam Indicated Cerclage in Twin Gestations</brief_title>
  <acronym>TWIN-PEIC</acronym>
  <official_title>Randomized Control Trial Physical Exam Indicated Cerclage in Twin Gestations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Albany Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wright State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baystate Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Università degli Studi di Brescia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maternal Fetal Medicine Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter randomized study designed to determine if physical exam indicated
      cerclage reduces the incidence of spontaneous preterm birth &lt;34 weeks in asymptomatic women
      with twin gestations and dilated cervix, diagnosed by pelvic exam between 16 to 23 6/7 weeks
      of gestation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twin pregnancies have 58% incidence of preterm delivery (before 37 weeks of gestation), with
      increased perinatal mortality and neonatal morbidity. No therapy has proven effective in
      preventing preterm birth in twins. When cervical dilation is identified before 24 weeks in
      singleton pregnancies, the risk of preterm birth is 90%-100%; based on a small series of
      cases, approximately 50% of twin gestations with cervical dilation will be delivered prior to
      viability (24 weeks) and the risk of preterm birth prior to 34 and 37 weeks was 85% and 100%.
      Cervical dilation is the worst prognostic factor for preterm birth. There are a small number
      of case reports of cervical cerclage in twin pregnancies with a dilated cervix that suggest
      similar outcomes to those in singleton pregnancies. The investigators' objective is to
      determine if physical exam indicated cerclage reduces the incidence of spontaneous preterm
      birth &lt;34 weeks and improve perinatal outcome in asymptomatic women with twin gestations and
      dilated cervix (1 to 5 cm) between 16 to 23 6/7 weeks of gestation.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    due to significant decrease of perinatal mortality in the cerclage group
  </why_stopped>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">December 12, 2019</completion_date>
  <primary_completion_date type="Actual">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preterm delivery less than 34 weeks</measure>
    <time_frame>at delivery</time_frame>
    <description>Incidence of preterm birth less than 34 weeks (any indication)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spontaneous preterm birth less than 34</measure>
    <time_frame>at delivery</time_frame>
    <description>Incidence of spontaneous preterm birth less than 34 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preterm delivery less than &lt;32 weeks, &lt;28 weeks, or &lt;24 weeks</measure>
    <time_frame>at delivery</time_frame>
    <description>Incidence of preterm birth less than &lt;32 weeks, &lt;28 weeks, or &lt;24 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean gestational age at delivery</measure>
    <time_frame>at delivery</time_frame>
    <description>Mean value of gestational age at delivery (weeks)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birth weight at birth</measure>
    <time_frame>at delivery</time_frame>
    <description>Mean value (grams)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gestational age at spontaneous rupture of membranes</measure>
    <time_frame>at presentation of rupture membranes</time_frame>
    <description>Mean value (weeks) through study completion</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Chorioamnionitis</measure>
    <time_frame>Time of delivery</time_frame>
    <description>Incidence</description>
  </other_outcome>
  <other_outcome>
    <measure>Composite adverse neonatal outcome</measure>
    <time_frame>Incidence between birth and 28 days of age</time_frame>
    <description>Includes necrotizing enterocolitis, intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia, retinopathy, blood-culture proven sepsis</description>
  </other_outcome>
  <other_outcome>
    <measure>Fetal demise</measure>
    <time_frame>Incidence before delivery</time_frame>
    <description>Incidence</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal death</measure>
    <time_frame>Incidence between birth and 28 days of age</time_frame>
    <description>Incidence</description>
  </other_outcome>
  <other_outcome>
    <measure>Perinatal death</measure>
    <time_frame>Incidence before and after birth ulntil 28 days of age</time_frame>
    <description>Incidence</description>
  </other_outcome>
  <other_outcome>
    <measure>Maternal death</measure>
    <time_frame>Between birth and 6 weeks postpartum</time_frame>
    <description>Incidence</description>
  </other_outcome>
  <other_outcome>
    <measure>Interval between diagnosis and delivery</measure>
    <time_frame>at delivery</time_frame>
    <description>Mean value (days) through study completion</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Twin Pregnancy, Antepartum Condition or Complication</condition>
  <condition>Preterm Birth</condition>
  <condition>Cervical Dilation Premature</condition>
  <arm_group>
    <arm_group_label>Physical exam indicated cerclage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cerclage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expectant management</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No cerclage</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Physical exam indicated cerclage</intervention_name>
    <description>Cervical cerclage</description>
    <arm_group_label>Physical exam indicated cerclage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Pregnant women older than 18 years of age

          2. Diamniotic twin pregnancy

          3. Cervical dilation between 1 to 5 cm and/or visible membranes by pelvic exam or
             speculum exam between at 16-23 6/7 weeks gestation

        Exclusion Criteria:

          1. Singleton pregnancy or higher order than twins multiple gestation

          2. Cervical dilation more than 5 cm

          3. Amniotic membranes prolapsed beyond external os into the vagina, unable to visualize
             cervical tissue

          4. More than 24 weeks of gestation

          5. Multifetal reduction after 14 weeks

          6. Monoamniotic twins

          7. Twin-twin transfusion syndrome

          8. Ruptured amniotic membranes at the time of diagnosis of dilated cervix

          9. Major fetal structural anomaly

         10. Fetal chromosomal abnormality

         11. Cerclage already in place for other indications

         12. Active vaginal bleeding

         13. Suspicion of clinical or biochemical chorioamnionitis

         14. Painful regular uterine contractions

         15. Labor (progressing cervical dilation)

         16. Placenta previa
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amanda Roman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>amanda.roman@jefferson.edu</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>George Washington University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wright State University</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Maternal Fetal Medicine St David's Health Care</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bologna University</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Brescia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università degli Studi di Napoli &quot;Federico II&quot;</name>
      <address>
        <city>Naples</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Poland</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Australia</country>
    <country>Denmark</country>
    <country>Spain</country>
  </removed_countries>
  <reference>
    <citation>Hamilton BE, Hoyert DL, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2010-2011. Pediatrics. 2013 Mar;131(3):548-58. doi: 10.1542/peds.2012-3769. Epub 2013 Feb 11.</citation>
    <PMID>23400611</PMID>
  </reference>
  <reference>
    <citation>Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, Mercer BM, Meis PJ, Moawad AH, Das A, Caritis SN, McNellis D. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):1047-53.</citation>
    <PMID>8885774</PMID>
  </reference>
  <reference>
    <citation>Conde-Agudelo A, Romero R, Hassan SS, Yeo L. Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010 Aug;203(2):128.e1-12. doi: 10.1016/j.ajog.2010.02.064. Epub 2010 Jun 23. Review.</citation>
    <PMID>20576253</PMID>
  </reference>
  <reference>
    <citation>Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, Varner M, Malone F, Iams JD, Mercer BM, Thorp J, Sorokin Y, Carpenter M, Lo J, Ramin S, Harper M, Anderson G; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med. 2007 Aug 2;357(5):454-61.</citation>
    <PMID>17671253</PMID>
  </reference>
  <reference>
    <citation>Schuit E, Stock S, Groenwold RH, Maurel K, Combs CA, Garite T, Spong CY, Thom EA, Rouse DJ, Caritis SN, Saade GR, Zachary JM, Norman JE, Rode L, Klein K, Tabor A, Cetingöz E, Morrison JC, Magann EF, Briery CM, Serra V, Perales A, Meseguer J, Nassar AH, Lim AC, Moons KG, Kwee A, Mol BW. Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials. BMC Pregnancy Childbirth. 2012 Mar 15;12:13. doi: 10.1186/1471-2393-12-13.</citation>
    <PMID>22420582</PMID>
  </reference>
  <reference>
    <citation>Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Klein K, Rode L, Soma-Pillay P, Fusey S, Cam C, Alfirevic Z, Hassan SS. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012 Feb;206(2):124.e1-19. doi: 10.1016/j.ajog.2011.12.003. Epub 2011 Dec 11. Review.</citation>
    <PMID>22284156</PMID>
  </reference>
  <reference>
    <citation>Saccone G, Rust O, Althuisius S, Roman A, Berghella V. Cerclage for short cervix in twin pregnancies: systematic review and meta-analysis of randomized trials using individual patient-level data. Acta Obstet Gynecol Scand. 2015 Apr;94(4):352-8. doi: 10.1111/aogs.12600. Epub 2015 Mar 1. Review.</citation>
    <PMID>25644964</PMID>
  </reference>
  <reference>
    <citation>Roman A, Rochelson B, Fox NS, Hoffman M, Berghella V, Patel V, Calluzzo I, Saccone G, Fleischer A. Efficacy of ultrasound-indicated cerclage in twin pregnancies. Am J Obstet Gynecol. 2015 Jun;212(6):788.e1-6. doi: 10.1016/j.ajog.2015.01.031. Epub 2015 Jan 28.</citation>
    <PMID>25637840</PMID>
  </reference>
  <reference>
    <citation>Rebarber A, Bender S, Silverstein M, Saltzman DH, Klauser CK, Fox NS. Outcomes of emergency or physical examination-indicated cerclage in twin pregnancies compared to singleton pregnancies. Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:43-7. doi: 10.1016/j.ejogrb.2013.11.016. Epub 2013 Nov 28.</citation>
    <PMID>24321466</PMID>
  </reference>
  <reference>
    <citation>Gupta M, Emary K, Impey L. Emergency cervical cerclage: predictors of success. J Matern Fetal Neonatal Med. 2010 Jul;23(7):670-4. doi: 10.3109/14767050903387011.</citation>
    <PMID>19883267</PMID>
  </reference>
  <reference>
    <citation>Zanardini C, Pagani G, Fichera A, Prefumo F, Frusca T. Cervical cerclage in twin pregnancies. Arch Gynecol Obstet. 2013 Aug;288(2):267-71. doi: 10.1007/s00404-013-2758-3. Epub 2013 Feb 21.</citation>
    <PMID>23430029</PMID>
  </reference>
  <reference>
    <citation>Miller ES, Rajan PV, Grobman WA. Outcomes after physical examination-indicated cerclage in twin gestations. Am J Obstet Gynecol. 2014 Jul;211(1):46.e1-5. doi: 10.1016/j.ajog.2014.03.034. Epub 2014 Mar 18.</citation>
    <PMID>24657791</PMID>
  </reference>
  <reference>
    <citation>Berghella V, Roman A. Cerclage in twins: we can do better! Am J Obstet Gynecol. 2014 Jul;211(1):5-6. doi: 10.1016/j.ajog.2014.03.037.</citation>
    <PMID>24972530</PMID>
  </reference>
  <reference>
    <citation>Liem S, Schuit E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, Brons J, Duvekot H, Bijvank BN, Franssen M, Gaugler I, de Graaf I, Oudijk M, Papatsonis D, Pernet P, Porath M, Scheepers L, Sikkema M, Sporken J, Visser H, van Wijngaarden W, Woiski M, van Pampus M, Mol BW, Bekedam D. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial. Lancet. 2013 Oct 19;382(9901):1341-9. doi: 10.1016/S0140-6736(13)61408-7. Epub 2013 Aug 5.</citation>
    <PMID>23924878</PMID>
  </reference>
  <reference>
    <citation>Althuisius SM, Dekker GA, Hummel P, van Geijn HP; Cervical incompetence prevention randomized cerclage trial. Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol. 2003 Oct;189(4):907-10.</citation>
    <PMID>14586323</PMID>
  </reference>
  <reference>
    <citation>Roman A, Rochelson B, Martinelli P, Saccone G, Harris K, Zork N, Spiel M, O'Brien K, Calluzzo I, Palomares K, Rosen T, Berghella V, Fleischer A. Cerclage in twin pregnancy with dilated cervix between 16 to 24 weeks of gestation: retrospective cohort study. Am J Obstet Gynecol. 2016 Jul;215(1):98.e1-98.e11. doi: 10.1016/j.ajog.2016.01.172. Epub 2016 Jan 28.</citation>
    <PMID>26827881</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>June 29, 2015</study_first_submitted>
  <study_first_submitted_qc>July 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2015</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cervical cerclage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De identified data</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>June 2020 2 years</ipd_time_frame>
    <ipd_access_criteria>x</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 20, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/84/NCT02490384/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 8, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/84/NCT02490384/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

